Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin or Plasma Exchange in a Matched Patient Cohort for the Treatment of Guillain-Barr Syndrome

ANNX Stock  USD 5.28  0.05  0.96%   
Slightly above 53% of Annexon's investor base is interested to short. The analysis of the overall investor sentiment regarding Annexon suggests that many traders are impartial. Annexon's investing sentiment can be driven by a variety of factors including economic data, Annexon's earnings reports, geopolitical events, and overall market trends.
  
Real-World Evidence Study Strengthens the Body of Evidence Supporting ANX005 for Treatment of GBS ANX005 Phase 3 Population Was Matched 11 on...

Read at globenewswire.com
Macroaxis News: globenewswire.com
  

Annexon Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Annexon can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Annexon Fundamental Analysis

We analyze Annexon's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Annexon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Annexon based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Annexon is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Annexon Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Annexon stock to make a market-neutral strategy. Peer analysis of Annexon could also be used in its relative valuation, which is a method of valuing Annexon by comparing valuation metrics with similar companies.

Peers

Annexon Related Equities

CNSPCns Pharmaceuticals   10.00   
0%
100.0%
ZURAZura Bio   4.39   
0%
43.0%
RLAYRelay Therapeutics   4.33   
0%
43.0%
RCUSArcus Biosciences   2.97   
0%
29.0%
ABOSAcumen Pharmaceuticals   2.78   
0%
27.0%
CGEMCullinan Oncology   2.33   
0%
23.0%
HEPAHepion Pharmaceuticals   2.04   
0%
20.0%
INZYInozyme Pharma   0.67   
0%
6.0%
AMLXAmylyx Pharmaceuticals   0.49   
0%
4.0%
IMMXImmix Biopharma   0.46   
0%
4.0%
BPMCBlueprint Medicines   0.21   
0%
2.0%
DAWNDay One   0.78   
7.0%
0%
WVEWave Life   2.89   
28.0%
0%
INABIn8bio   4.00   
40.0%
0%
XFORX4 Pharmaceuticals   4.69   
46.0%
0%
GPCRStructure Therapeutics   6.91   
69.0%
0%

Additional Tools for Annexon Stock Analysis

When running Annexon's price analysis, check to measure Annexon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexon is operating at the current time. Most of Annexon's value examination focuses on studying past and present price action to predict the probability of Annexon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexon's price. Additionally, you may evaluate how the addition of Annexon to your portfolios can decrease your overall portfolio volatility.